[The programmed therapy of acute lymphoblastic leukemia in adults]

Ter Arkh. 1992;64(8):82-7.
[Article in Russian]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Asparaginase / administration & dosage
  • Asparaginase / adverse effects
  • Bone Marrow / drug effects
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Drug Evaluation
  • Humans
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Recurrence
  • Remission Induction
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Cytarabine
  • Vincristine
  • Cyclophosphamide
  • Prednisolone
  • Asparaginase
  • Daunorubicin

Supplementary concepts

  • LOP protocol
  • RACOP protocol